A Study of ABTL0812 in Pancreatic Cancer

NCT03417921 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped We opened another study.

Conditions

Pancreatic Cancer

Interventions

DRUG: ABTL0812
DRUG: Gemcitabine and nab-paclitaxel

Sponsor

Ability Pharmaceuticals SL

Collaborators

[object Object]